Elizabeth Alexander

Elizabeth Alexander serves as the Vice President of Clinical Research at Septerna, bringing extensive experience in clinical development from previous roles, including Senior Vice President of Clinical Development at Jasper Therapeutics and Vice President of Clinical Research and Development at Vir Biotechnology, Inc. Elizabeth has a robust background overseeing various therapeutic areas, particularly in infectious diseases and respiratory medicine, with notable contributions to COVID-19 development programs and the lefamulin development initiative at Nabriva Therapeutics. Elizabeth’s academic credentials include an MD from Joan & Sanford I. Weill Medical College of Cornell University and a Bachelor of Arts in Psychology from Stanford University, along with a Master's in Clinical Investigation from Weill Cornell Graduate School of Medical Sciences.